The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis

by Yingzhu Yang, Nannan Du, Laidi Xie, Jing Jiang, Jiahang Mo, Jiaze Hong, Danyi Mao, Derry Minyao Ng, Huiwei Shi
Published 2020-07-01

Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection

by Lihu Gu, Mian Wang, Xuena Cui, Jiahang Mo, Lingling Yuan, Feiyan Mao, Kang Zhang, Derry Minyao Ng, Ping Chen, Dongjie Wang
Published 2020-10-01

Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis

by Jiahang Mo, Xiao Hu, Lihu Gu, Bangsheng Chen, Parikshit Asutosh Khadaroo, Zefeng Shen, Lei Dong, Yuqi Lv, Marylin Nyaradzo Chitumba, Jiequan Liu
Published 2020-01-01